Keyphrases
Tolerability
100%
Acute Decompensated Heart Failure
100%
Failure Analysis
100%
Sacubitril-valsartan
100%
Intolerance
50%
Heart Failure with Preserved Ejection Fraction (HFpEF)
40%
Multivariable
20%
Risk Factors
10%
Renal Disease
10%
Creatinine
10%
Systolic Blood Pressure
10%
Low Serum
10%
Predictive Models
10%
Insulin
10%
Heart Failure Trials
10%
Angiotensin-converting Enzyme Inhibitor (ACEi)
10%
Symptomatology
10%
New York Heart Association Functional Class
10%
Intolerant
10%
Clinical Parameters
10%
Mean Arterial Pressure
10%
Mitral Regurgitation
10%
Angiotensin Receptor Blockers
10%
Implantable Defibrillator
10%
Twice a Day
10%
Unblinding
10%
Serum Chloride
10%
LCZ696
10%
Renin-angiotensin System Antagonists
10%
Cardiac Resynchronization Device
10%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Tolerability
100%
Valsartan/Sacubitril
100%
Heart Failure with Reduced Ejection Fraction
40%
Renin
10%
Angiotensin
10%
Creatinine
10%
Dipeptidyl Carboxypeptidase Inhibitor
10%
Symptomatology
10%
Angiotensin Receptor Antagonist
10%
Mitral Valve Regurgitation
10%
Sacubitril Plus Valsartan
10%